Overview

Lipid Emulsion Infusion and COVID-19 Patients

Status:
Completed
Trial end date:
2021-09-26
Target enrollment:
Participant gender:
Summary
Investigators suggest that early administration of intravenous lipid emulsion (ILE) affect the inflammatory response and improve outcome in COVID-19. The aim of this trial is to study the effect of fish-oil-based intravenous lipid emulsion (FOBLE) supplementation added to enteral nutrition on shift to ICU for upgrading oxygenation &/or ventilation in moderate cases of Covid-19 diseased patients requiring only supplemental oxygen in form of simple nasal cannula or venturi mask oxygen (during 7 days admission).
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
SMOFlipid